How Autoimmune Diseases Attack the Body: Types, Causes, and Treatment

When the Body's Defense System Turns Inward

Roughly 24 million Americans live with an autoimmune disease, according to the National Institutes of Health. Some estimates that include broader diagnostic criteria push that number above 50 million. The immune system—designed to identify and destroy bacteria, viruses, and other foreign invaders—begins attacking the body's own tissues instead. The result ranges from mild discomfort to organ failure. Over 80 distinct autoimmune conditions have been identified, and researchers suspect more remain unclassified.

No two autoimmune diseases behave the same way. But all share one fundamental error.

The Mechanism Behind the Misfiring

In a healthy immune system, T cells and B cells learn during development to distinguish self from non-self. This education occurs primarily in the thymus (for T cells) and bone marrow (for B cells). Cells that react to the body's own proteins are normally eliminated through a process called clonal deletion. Autoimmunity occurs when this quality control fails.

Several breakdown points can trigger the malfunction:

• Molecular mimicry—a pathogen's proteins resemble the body's own proteins, confusing immune cells
• Failure of regulatory T cells (Tregs) that normally suppress self-reactive immune responses
• Tissue damage from infection or injury that exposes normally hidden self-antigens
• Epigenetic changes that alter gene expression in immune cells
• Hormonal influences, which may explain why roughly 78% of autoimmune patients are women

Once activated, self-reactive immune cells produce autoantibodies—proteins that target the body's own tissues. Chronic inflammation follows. Damage accumulates.

The Most Common Autoimmune Conditions

Why Diagnosis Takes an Average of 4.5 Years

A 2019 survey by the American Autoimmune Related Diseases Association found that the average autoimmune patient sees four doctors over 4.5 years before receiving a correct diagnosis. Symptoms overlap significantly across conditions. Fatigue, joint pain, and inflammation appear in dozens of different diseases. Many early symptoms are intermittent, waxing and waning in unpredictable flare cycles.

Diagnostic tools include:

• Antinuclear antibody (ANA) test—positive in many autoimmune conditions but not specific to any single one
• Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)—markers of inflammation
• Disease-specific antibodies: anti-CCP for rheumatoid arthritis, anti-dsDNA for lupus
• Imaging studies (MRI, ultrasound) to detect joint or organ damage
• Tissue biopsy in cases like celiac disease or vasculitis

No single test confirms most autoimmune diseases. Diagnosis relies on clinical criteria combining symptoms, lab results, and imaging findings.

The Gender Gap in Autoimmune Disease

Women account for roughly 78% of autoimmune disease patients. The reasons are not fully understood, but research points to several contributing factors. Estrogen enhances immune responses, which provides stronger defense against infections but may also increase the likelihood of self-reactive immune activity. The X chromosome carries a disproportionate number of immune-related genes, and women have two copies. X-chromosome inactivation—where one copy is silenced in each cell—is sometimes incomplete, potentially allowing dual expression of immune genes. A 2024 study in Cell identified a molecular mechanism involving Xist, an RNA molecule involved in X-chromosome inactivation, that triggers autoimmune responses in female mice.

Treatment Approaches and Their Trade-Offs

Autoimmune treatment aims to reduce immune activity without leaving the patient vulnerable to infections. That balance is difficult to achieve.

The Biologic Revolution

The introduction of TNF inhibitors in the late 1990s transformed treatment for rheumatoid arthritis, Crohn's disease, and psoriasis. Before biologics, many patients faced progressive joint destruction or uncontrolled inflammation despite conventional therapy. Biologics reduced that progression substantially. The trade-off is cost—many biologics exceed $50,000 per year without insurance—and the increased vulnerability to opportunistic infections.

Lifestyle Factors and Emerging Research

Research published in journals including Nature Reviews Immunology and The Lancet has identified environmental triggers that may initiate or worsen autoimmune responses. Smoking doubles the risk of rheumatoid arthritis in genetically susceptible individuals. Epstein-Barr virus infection is now strongly linked to multiple sclerosis risk, with a 2022 Science study showing a 32-fold increase in MS risk after EBV infection.

The gut microbiome is another active research area. Dysbiosis—an imbalance in gut bacterial populations—has been observed in patients with lupus, type 1 diabetes, and inflammatory bowel disease, though whether it is a cause or consequence remains under investigation.

• Vitamin D deficiency correlates with higher autoimmune disease rates in northern latitudes
• Stress hormones (cortisol, adrenaline) can modulate immune function and trigger flares
• Sleep deprivation increases inflammatory cytokine production
• Mediterranean diet patterns show modest anti-inflammatory benefits in clinical trials

CAR-T cell therapy, originally developed for blood cancers, is now being tested for severe autoimmune diseases. Early results from trials at the University of Erlangen-Nuremberg in Germany showed complete remission in lupus patients who had failed all conventional treatments. The approach reprograms a patient's own T cells to eliminate the self-reactive B cells driving the disease. These trials are small—fewer than 20 patients as of 2024—but the results have generated considerable interest.

Autoimmune diseases remain incurable by conventional means. Remission is achievable for some patients, and treatment continues to improve. The gap between symptom onset and effective treatment remains the most consequential problem in the field.

This article is for informational purposes only. Consult a qualified professional.